CD8A and neoplasm: Further investigation of the NRTUA-elicited antitumor mechanisms could reveal the specific targets in mammalian cell signaling and transcriptional pathways that can be manipulated to break tumor immune tolerance and rescue natural and effective CD8+ T-cell immunity to cancer.